期刊文献+

三联疗法联合复合乳酸菌胶囊根除幽门螺旋杆菌的临床观察 被引量:2

Clinical observation of triple therapy combined with Lactobacillus complex capsules for eradication of Helicobacter pylorig
下载PDF
导出
摘要 目的:探讨三联疗法联合复合乳酸菌胶囊根除幽门螺旋杆菌(Helicobacter pylori,Hp)的疗效与安全性。方法:将100例Hp感染患者随机分成两组,观察组51例,对照组49例,两组均给予三联疗法,观察组在三联疗法基础上给予复合乳酸菌胶囊(聚克)0.66g,tid,治疗14d后两组停用三联疗法药物,观察组继续服用复合乳酸菌胶囊(聚克)14d。结果:观察组Hp根除率为80.4%,对照组根除率为65.3%。两组比较差异显著(P<0.05)。对照组和观察组在治疗前、后3d对菌群失调影响差异无统计学意义(P>0.05);治疗后7d,对照组发生菌群失调12例,观察组发生菌群失调4例,两组比较差异有统计学意义(P<0.05);治疗14d后,对照组发生菌群失调17例,观察组发生菌群失调6例,两组比较差异显著(P<0.01)。结论:三联疗法联合复合乳酸菌胶囊根除Hp效果优于仅采用三联疗法,并且可减少菌群失调现象,值得临床推广。 Objective:To investigate the efficacy and safety of the triple therapy combined with Lactobacillus complex capsules to eradicate of Helicobacter pylori. Method:The patients were randomly divided into two groups of 100 patients infected with HP, 51 cases in observation group, 49 cases in the control group. Both of the two groups were treated with triple therapy, meanwhile the observation group were given Lactobacillus complex capsules (Ju Ke) 0.66g,tid based on the triple therapy. After 14 days of therapy both of the two groups disabled triple therapy, and the observation group continued to take Lactobacillus complex capsules (Ju Ke) 14 days. Result: The Hp eradication rate of observation group was 80.3%, and the eradication rate of control group was 65.3%. There were significant differences between two groups (P〈0.05). There was no statistical significance between the observation group and the control group to flora imbalance effect before and after 3 days treatment (P〉0.05). After 7 days treatment, there was 12 flora imbalance cases in control group and 4 flora imbalance cases in observation group, and had significant difference between two groups (P〈0.05). After 14 days treatment, there was 17 flora imbalance cases in control group and 6 flora imbalance cases in observation group, and had significant differences between two groups (P〈0.01). Conclusion: HP eradication effect of Triple therapy combined with Lactobaeillus capsule was better than that of triple therapy, and Triple therapy combined with Lactobacilluscapsule can reduce bacterium maladjusted phenomenon more conducive to clinical practice.
出处 《北方药学》 2015年第3期42-43,共2页 Journal of North Pharmacy
关键词 复合乳酸菌胶囊 三联疗法 幽门螺旋杆菌 Lactobacillus complex capsules Triple therapy Helicobacter pylori
  • 相关文献

参考文献4

二级参考文献39

  • 1牟方宏,胡伏莲.又一新的微生态制剂——美常安[J].临床药物治疗杂志,2004,2(5):60-60. 被引量:21
  • 2成虹,胡伏莲.北京地区幽门螺杆菌耐药情况及其变化趋势[J].中华医学杂志,2005,85(39):2754-2757. 被引量:176
  • 3曹艳菊,张豫生,屈昌民,袁群.幽门螺杆菌治疗中抗生素相关性腹泻的预防[J].中华医院感染学杂志,2006,16(5):559-560. 被引量:19
  • 4成虹,胡伏莲,李江.幽门螺杆菌耐药性对其根除治疗影响的研究[J].中华医学杂志,2006,86(38):2679-2682. 被引量:97
  • 5Myllyluoma E, Veijola L, Ahlroos, et al. Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy-a placebo controlled,double-blind randomized pilot study[J]. Aliment Pharmacol Ther, 2005,21 (10) :1263.
  • 6Hamilton-Miller JM. The role of probiotics in the treatment and prevention of Helicobaeter pylori infeetion[JJ. Int J Antimierobial Agents,2003,22(4) :360.
  • 7Cheon JH, Kim N, Lee DH, et al. Trial of moxifloxacincontaining triple therapy after initial and second-line treatment failures for helicobacter pylori infection[J]. Korean J Gastroenterol,2005,45(2):111.
  • 8Lesbros PD, Corthesy TI, Blum AL. Helicobacter pylori and probiotics[J]. J Nutr,2007,137(3 Suppl 2):812S.
  • 9Sheu BS,Wu J J, Lo CY,et al. Impact of supplement With Lactobaeitlus and Bifidobacterium-eontaining yogurt on triple therapy for Helicobacter pylori eradication[J]. Aliment Pharmacol Ther,2002,16 : 1669.
  • 10Cremonini F,Di Caro S,Covino M, et al. Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects:a parallel group, triple blind, placebo-controlled study [J]. Am J Gastroenterol, 2002, 97:2744.

共引文献99

同被引文献14

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部